Lab

1976 Abitur, Gymnasium 'Kurt-Schumacher-Allee', Bremen, Germany

1976-1983 University of Bremen, Germany. Department of Chemistry:

1983 Dipl. Chem. (M.S.), Institute of Organic Chemistry, University of Bremen, Germany.

1987 Dr. rer. nat. (Ph.D.), Institute of Organic Chemistry, University of Bremen, Germany.

1996 Dr. med. habil. (Habilitation), Institute of Pharmacology & Toxicology, Technical University of Munich, Germany.

2009 - Present Professor (tenure), Department of Pharmacology, University of Vermont, College of Medicine,

2004 – 2009 Associate Professor (tenure), Department of Pharmacology, University of Vermont, College of Medicine,

1998 - 2004 Assistant Professor, Department of Pharmacology, University of Vermont, College of Medicine,

1997 - 1998 Privatdozent (Senior Lecturer), Institute of Pharmacology and Toxicology, Faculty of Medicine, Technical University of Munich, Germany

1991 - 1997 Assistant (Lecturer), Institute of Pharmacology and Toxicology, Technical University of Munich, Germany

1989 - 1991 Research Associate, University of California at San Diego, California

1987 - 1989 Post-Doctoral Fellow, University of California at San Diego, California

1983 - 1987 Graduate Student and Teaching Assistant, University of Bremen, Institute of Organic Chemistry, Bremen, Germany

1998 - 2018 Research Grant, R37 DK053832, Co-investigator (PI: Mark T. Nelson). National Institute of Health, NIH/NIDDK. Ca²⁺ sparks and urinary bladder smooth muscle excitability. $215,000

2008 - 2013 Research Grant, R01 HL68991-02. Principal Investigator. National Institute of Health, NIH/NHLBI. Title: Exploring vasomotor mechanism using new PKG inhibitors and cGMP biosensors. $250,000

2010 - 2012 Internal Research Grant (IGP), College of Medicine, UVM. Title: The crystal structure of cGMP-dependent protein kinase

2008 - 2012 Research Grant, R01 HL085646-01, Co-investigator (PI: Albert van der Vliet). National Institute of Health, NIH/NHLBI. Title: Dual Oxidase in Airway Epithelial Repair and Remodeling. $250,000

2001 - 2012 Research Grant, R01 DK56644, Co-investigator (PI: Steven Lidofsky). National Institute of Health, NIH/NIDDK. Title: Mechanisms of cell volume regulation in liver. $212,500

2006 - 2011 Research Grant BayerHealthcare, Germany. Principal Invesigator. Title: Characterization of PKG Activators and Crystallization of PKG and Co-Crystallisation with PKG Activators. $50,000

2007 - 2009 Research Grant BayerHealthcare, Germany. Principal Investigator. Title: Analyzing the redox equilibrium of soluble guanylyl cyclase in vascular smooth muscle using BAY 58-2667 and cGMP biosensors. $37,000

1997 Venia legendi, (Privatdozent), Munich/Bavaria, Germany

1987 Doctor Graduation with honors, summa cum laude, Bremen, Germany

2010 Lavogina D, Nickl CK, Enkvist E, Raidaru G, Lust M, Vaasa A, Uri A, Dostmann WR. Adenosine analogue-oligo-arginine conjugates (ARCs) serve as high-affinity inhibitors and fluorescence probes of type I cGMP-dependent protein kinase (PKGIalpha). Biochim Biophys Acta. 1804:1857-1868, 2010.

2009 Steiner JA, Carneiro AM, Wright J, Matthies HJ, Prasad HC, Nicki CK, Dostmann WR, Buchanan CC, Corbin JD, Francis SH, Blakely RD. cGMP-dependent protein kinase Ialpha associates with the antidepressant-sensitive serotonin transporter and dictates rapid modulation of serotonin uptake. Mol Brain, 5;2(1):26, 20093

For a complete list of Wolfgang Dostmann's publications, please visit PubMed.